Additionally, this might have a meaning in cancer lesions, where cancer-derived sPD-L1 would block membrane-bound PD-L1 molecules in the presence of the compounds evaluated in this study, or membrane-bound PD-L1 molecules would reciprocally block each other at the cell-cell interface of cancer cells. The gene discussed is CD274; the disease is cancer.